Moderna Inc (MRNA)

$40.58 +0.98 (2.47%)
Market Cap 15.47B
Revenue (ttm) 3.24B
Net Income (ttm) -3.56B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -110.04%
Debt to Equity Ratio 0.00
Volume 19,498,201
Avg Vol 10,992,814
Day's Range N/A - N/A
Shares Out 390.73M
Stochastic %K 89%
Beta 1.17
Analysts Hold
Price Target $35.15

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
TradeTherapyLLC
TradeTherapyLLC Jan. 15 at 6:00 AM
$MRNA High volume + small candles + price pinned in a range can be a tell: institutions may be quietly building exposure. The trigger is a reclaim of the shorter-term moving averages as they flatten. If that happens, moves out of these ranges can get fast. Disclosure: No position. Considering long. Educational only, not investment advice. https://youtu.be/1kfyiHpfXyw
0 · Reply
Mel_r7
Mel_r7 Jan. 15 at 4:48 AM
$MRNA predictions and levels for tomorrow and end of the week anyone?
0 · Reply
GoAt2OG
GoAt2OG Jan. 15 at 4:33 AM
$MRNA short position coming very soon 😏
0 · Reply
DreamChaser23
DreamChaser23 Jan. 15 at 1:42 AM
$MRNA I GOT IN AT THE BOTTOM. 2027 EXP 😁🤑
0 · Reply
taxplanr
taxplanr Jan. 15 at 1:26 AM
malignantRNA has tainted the blood supply $BNTX $MRNA $PFE https://rumble.com/v74c0u8-mrna-has-tainted-our-blood-supply-and-breaking-news-from-scotus-boys-are-bo.html
0 · Reply
___dog___
___dog___ Jan. 15 at 1:22 AM
$MRNA 40 naaaa we can't have this.
0 · Reply
NioEVisBestEv
NioEVisBestEv Jan. 15 at 12:00 AM
$NVAX $MRNA so is the jp morgan conference gonna pump our bags or what
1 · Reply
Arunas1
Arunas1 Jan. 14 at 11:48 PM
$MRNA -7
1 · Reply
StageAnalysis
StageAnalysis Jan. 14 at 10:50 PM
$MRNA breakout from the broader 9 month base structure in early Stage 2
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 14 at 10:26 PM
$MRNA $44.82+
0 · Reply
Latest News on MRNA
Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story

Jan 13, 2026, 8:15 AM EST - 1 day ago

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story

Moderna, Inc. (MRNA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 10:26 PM EST - 2 days ago

Moderna, Inc. (MRNA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance.

Jan 12, 2026, 8:51 AM EST - 2 days ago

Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance.

Moderna expects $1.9 billion in sales, trims costs forecast for 2025

Jan 12, 2026, 7:12 AM EST - 2 days ago

Moderna expects $1.9 billion in sales, trims costs forecast for 2025

Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:00 AM EST - 2 days ago

Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Moderna Stock Fights Back Against Four‑Year Curse With 20% Blastoff And A Golden Cross

Jan 7, 2026, 9:03 AM EST - 7 days ago

Moderna Stock Fights Back Against Four‑Year Curse With 20% Blastoff And A Golden Cross

America's new vaccine doctrine for children replaces data with dogma

Jan 6, 2026, 11:55 AM EST - 8 days ago

America's new vaccine doctrine for children replaces data with dogma

PFE

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Jan 5, 2026, 7:00 AM EST - 9 days ago

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition

Dec 18, 2025, 7:02 AM EST - 27 days ago

Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition

CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate

Dec 18, 2025, 7:00 AM EST - 27 days ago

CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate

Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 17, 2025, 7:00 AM EST - 4 weeks ago

Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

Dec 15, 2025, 7:00 AM EST - 4 weeks ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 2, 2025, 1:33 PM EST - 6 weeks ago

Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

S&P 500 Gains and Losses Today: Moderna Falls; Synopsys Stock Climbs on Nvidia Partnership

Dec 1, 2025, 4:50 PM EST - 6 weeks ago

S&P 500 Gains and Losses Today: Moderna Falls; Synopsys Stock Climbs on Nvidia Partnership

SNPS

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 6 weeks ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX NVAX PFE

Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More

Dec 1, 2025, 12:50 PM EST - 6 weeks ago

Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More

COIN HOOD SNPS

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 6 weeks ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX NVAX PFE

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

Dec 1, 2025, 9:59 AM EST - 6 weeks ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

NVAX

Moderna, Inc. (MRNA) Analyst/Investor Day Transcript

Nov 24, 2025, 8:03 PM EST - 7 weeks ago

Moderna, Inc. (MRNA) Analyst/Investor Day Transcript

Moderna takes $1.5 billion loan, expects 10% revenue growth next year

Nov 20, 2025, 7:03 AM EST - 7 weeks ago

Moderna takes $1.5 billion loan, expects 10% revenue growth next year

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Nov 20, 2025, 7:00 AM EST - 7 weeks ago

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Nov 20, 2025, 7:00 AM EST - 7 weeks ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Moderna to complete US mRNA manufacturing network with $140 million investment

Nov 19, 2025, 8:44 AM EST - 2 months ago

Moderna to complete US mRNA manufacturing network with $140 million investment

Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities

Nov 19, 2025, 7:00 AM EST - 2 months ago

Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

Nov 18, 2025, 7:00 AM EST - 2 months ago

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

What Is Going On With Moderna Stock?

Nov 13, 2025, 9:25 AM EST - 2 months ago

What Is Going On With Moderna Stock?

Moderna, Inc. (MRNA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:26 PM EST - 2 months ago

Moderna, Inc. (MRNA) Q3 2025 Earnings Call Transcript

mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast

Nov 6, 2025, 12:29 PM EST - 2 months ago

mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast

Moderna trims top end of full-year forecast on weak COVID vaccine sales

Nov 6, 2025, 7:11 AM EST - 2 months ago

Moderna trims top end of full-year forecast on weak COVID vaccine sales

Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales

Nov 6, 2025, 7:09 AM EST - 2 months ago

Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 6, 2025, 7:00 AM EST - 2 months ago

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

Moderna Stock Is Sliding Monday: What's Going On?

Nov 3, 2025, 3:54 PM EST - 2 months ago

Moderna Stock Is Sliding Monday: What's Going On?

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

Nov 3, 2025, 7:00 AM EST - 2 months ago

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

Moderna: Focus On Cancer Vaccines, Not Buyout

Oct 31, 2025, 4:05 PM EDT - 2 months ago

Moderna: Focus On Cancer Vaccines, Not Buyout

Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?

Oct 31, 2025, 3:57 PM EDT - 2 months ago

Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?

S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges

Oct 30, 2025, 5:25 PM EDT - 2 months ago

S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges

META

Moderna Named a Top Employer by Science for Eleventh Consecutive Year

Oct 23, 2025, 2:42 PM EDT - 2 months ago

Moderna Named a Top Employer by Science for Eleventh Consecutive Year

Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection

Oct 23, 2025, 10:26 AM EDT - 2 months ago

Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection

Moderna to Host Investor Event - Analyst Day

Oct 23, 2025, 7:00 AM EDT - 2 months ago

Moderna to Host Investor Event - Analyst Day

Moderna ends development of CMV vaccine after trial failure

Oct 22, 2025, 4:34 PM EDT - 3 months ago

Moderna ends development of CMV vaccine after trial failure

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

Oct 22, 2025, 4:05 PM EDT - 3 months ago

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

Oct 19, 2025, 8:00 AM EDT - 3 months ago

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 3 months ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

BNTX

Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript

Oct 17, 2025, 4:06 PM EDT - 3 months ago

Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Oct 16, 2025, 7:00 AM EDT - 3 months ago

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Moderna: Q3 Earnings Preview - I Fear A Halloween Horror Show (Downgrade)

Oct 14, 2025, 4:57 PM EDT - 3 months ago

Moderna: Q3 Earnings Preview - I Fear A Halloween Horror Show (Downgrade)

Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients

Oct 13, 2025, 10:52 AM EDT - 3 months ago

Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress

Oct 12, 2025, 6:05 PM EDT - 3 months ago

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress

‘Fast Money' traders talk opportunities in health care stocks

Oct 1, 2025, 5:48 PM EDT - 3 months ago

‘Fast Money' traders talk opportunities in health care stocks

AMGN BIIB BMY IBB LLY MRK PFE

3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 3 months ago

3 Of My Favorite Biotech Stocks Under $10

DVAX FOLD NUVB PFE

TradeTherapyLLC
TradeTherapyLLC Jan. 15 at 6:00 AM
$MRNA High volume + small candles + price pinned in a range can be a tell: institutions may be quietly building exposure. The trigger is a reclaim of the shorter-term moving averages as they flatten. If that happens, moves out of these ranges can get fast. Disclosure: No position. Considering long. Educational only, not investment advice. https://youtu.be/1kfyiHpfXyw
0 · Reply
Mel_r7
Mel_r7 Jan. 15 at 4:48 AM
$MRNA predictions and levels for tomorrow and end of the week anyone?
0 · Reply
GoAt2OG
GoAt2OG Jan. 15 at 4:33 AM
$MRNA short position coming very soon 😏
0 · Reply
DreamChaser23
DreamChaser23 Jan. 15 at 1:42 AM
$MRNA I GOT IN AT THE BOTTOM. 2027 EXP 😁🤑
0 · Reply
taxplanr
taxplanr Jan. 15 at 1:26 AM
malignantRNA has tainted the blood supply $BNTX $MRNA $PFE https://rumble.com/v74c0u8-mrna-has-tainted-our-blood-supply-and-breaking-news-from-scotus-boys-are-bo.html
0 · Reply
___dog___
___dog___ Jan. 15 at 1:22 AM
$MRNA 40 naaaa we can't have this.
0 · Reply
NioEVisBestEv
NioEVisBestEv Jan. 15 at 12:00 AM
$NVAX $MRNA so is the jp morgan conference gonna pump our bags or what
1 · Reply
Arunas1
Arunas1 Jan. 14 at 11:48 PM
$MRNA -7
1 · Reply
StageAnalysis
StageAnalysis Jan. 14 at 10:50 PM
$MRNA breakout from the broader 9 month base structure in early Stage 2
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 14 at 10:26 PM
$MRNA $44.82+
0 · Reply
Partyrock
Partyrock Jan. 14 at 10:18 PM
$MRNA damn, i remember a few months ago when a politician went in at around 20s. And i was like should i too?
0 · Reply
Hammers_Only
Hammers_Only Jan. 14 at 10:04 PM
$MRNA hold up - this POS stock is up near 100% since 11/21/25??? Super quiet jump wtf....
0 · Reply
Raven67
Raven67 Jan. 14 at 9:22 PM
$MRNA This is time to average up or down… 100 plus will be faster than it went down Go mrna 🍀🍀🍀🍀
0 · Reply
taxplanr
taxplanr Jan. 14 at 9:18 PM
Why people are leaving oncologists $BNTX $MRNA $PFE https://makisw.substack.com/p/breaking-news-treatment-that-may?utm_source=post-email-title&publication_id=1385328&post_id=184575659&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
shooshmonk
shooshmonk Jan. 14 at 9:07 PM
$MRNA - $PLTR $RKLB have similarities. Maybe $HOOD as well
0 · Reply
10xby3
10xby3 Jan. 14 at 9:05 PM
$MRNA so many shorts are dead here - will to parabolic gamma
0 · Reply
YorkMeister
YorkMeister Jan. 14 at 9:03 PM
$IBRX how do they do it??! Today’s increase is not really based on this news, the big volume is definitely. See $TNXP $SRPT $MRNA without news, same level of gains. Are hedge funds guaranteed loss compensation through the back door by some ‘interested’ parties ? Would love to know the real story but market is full of fantasy, lies and shennenigans to ever find out - they know it.
1 · Reply
10xby3
10xby3 Jan. 14 at 8:52 PM
$MRNA going MUCH HIGHER 60-70 by end Jan
0 · Reply
free2dream
free2dream Jan. 14 at 8:49 PM
$MRNA move your asks higher, they will come and get it. WATCH $SRPT and $QURE very nice REVERSALS , all seriously undervalued. $XBI $LABU
0 · Reply
paulchriste
paulchriste Jan. 14 at 8:41 PM
$MRNA Sentiment-sensitive, confirmation is a breakout with volume and no immediate fade
0 · Reply
free2dream
free2dream Jan. 14 at 8:38 PM
$MRNA just enjoy the ride up, you'll be kicking yourself selling it . They all have to upgrade Moderna from their pathetic $20 price targets. $48.60 is the next resistance .
0 · Reply
free2dream
free2dream Jan. 14 at 8:37 PM
$MRNA $MRK should buy Moderna while it is still sub $20B . Idiotic not to, all the Moderna oncology trials have extremely good results . $XBI $SRPT
0 · Reply